As of 2026-03-22, the Intrinsic Value of Spruce Biosciences Inc (SPRB) is -182.08 USD. This SPRB valuation is based on the model Peter Lynch Fair Value. With the current market price of 58.40 USD, the upside of Spruce Biosciences Inc is -411.79%.
Based on its market price of 58.40 USD and our intrinsic valuation, Spruce Biosciences Inc (SPRB) is overvalued by 411.79%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -182.08 - -182.08 | -182.08 | -411.79% |
| P/E | (667.16) - (773.49) | (735.62) | -1359.6% |
| DDM - Stable | (228.77) - (711.80) | (470.29) | -905.3% |
| DDM - Multi | (185.88) - (478.21) | (271.03) | -564.1% |
| Market Cap (mil) | 62.49 |
| Beta | -19.07 |
| Outstanding shares (mil) | 1.07 |
| Enterprise Value (mil) | 13.58 |
| Market risk premium | 4.60% |
| Cost of Equity | 11.87% |
| Cost of Debt | 5.00% |
| WACC | 7.77% |